Baxter International, Inc.
Pharmaceutical firm reports loss of $0.28 per share
Published in Health Business Week, August 20th, 2004
The company reported a loss from continuing operations of $169 million, or $0.28 per diluted share, which includes after-tax charges of $414 million, or $0.68 per diluted share related to the 2004 restructuring initiatives and other items.
Excluding these special charges, earnings from continuing operations totaled $245 million, or $0.40 per diluted share, which is within the range of the company's previous guidance for the quarter of $0.37 to $0.41 per diluted share.
Given the company's announced plans to restate its financial results, all...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2004-08-20)
More Articles from Health Business Week
- Health Management Associates, Inc.
HMA reports record Q3; earnings per share increases 20% - Albemarle Corporation
Chemical supplier reports earnings of $0.50 per share - Becton, Dickinson and Company
Medical technology company reports 8% increase in revenue - Bio-One Corporation
Supplement maker to acquire majority interest in $17M Chinese firm - Biolase Technology, Inc.
Device firm anticipates 48-50% increase in revenue - Boston Scientific Corporation
Device firm reports 71% increase in net sales - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
